Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Circulating oncometabolite 2-hydroxyglutarate (2HG) as a potential surrogate biomarker in patients with isocitrate dehydrogenase mutant (IDHm) intrahepatic cholangiocarcinoma (ICC) Proceeding/Conference:Journal of Clinical Oncology | 2013 | ||
2014 | |||
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets Journal:Annals of Surgical Oncology | 2014 |